BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20524790)

  • 1. The problem of nodal disease in squamous cell carcinoma of the temporal bone.
    Zanoletti E; Danesi G
    Acta Otolaryngol; 2010 Aug; 130(8):913-6. PubMed ID: 20524790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
    Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
    Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of contralateral N0 neck in tonsillar squamous cell carcinoma.
    Lim YC; Lee SY; Lim JY; Shin HA; Lee JS; Koo BS; Kim SH; Choi EC
    Laryngoscope; 2005 Sep; 115(9):1672-5. PubMed ID: 16148715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell carcinoma of the temporal bone: results and management.
    Kunst H; Lavieille JP; Marres H
    Otol Neurotol; 2008 Jun; 29(4):549-52. PubMed ID: 18520589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of contralateral N0 neck in oral cavity squamous cell carcinoma.
    Koo BS; Lim YC; Lee JS; Choi EC
    Head Neck; 2006 Oct; 28(10):896-901. PubMed ID: 16721743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?
    Lim YC; Koo BS; Lee JS; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1232-5. PubMed ID: 16826066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcomes in surgical treatment of 72 cases of squamous cell carcinoma of the temporal bone.
    Chi FL; Gu FM; Dai CF; Chen B; Li HW
    Otol Neurotol; 2011 Jun; 32(4):665-9. PubMed ID: 21436754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of contralateral N0 neck in pyriform sinus carcinoma.
    Koo BS; Lim YC; Lee JS; Kim YH; Kim SH; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1268-72. PubMed ID: 16826073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level IIb lymph node metastasis in laryngeal squamous cell carcinoma.
    Lim YC; Lee JS; Koo BS; Choi EC
    Laryngoscope; 2006 Feb; 116(2):268-72. PubMed ID: 16467717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for squamous cell carcinoma of the temporal bone: extensive bone involvement or extensive soft tissue involvement?
    Ito M; Hatano M; Yoshizaki T
    Acta Otolaryngol; 2009 Nov; 129(11):1313-9. PubMed ID: 19863330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
    Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is dissection of level IV absolutely necessary in elective lateral neck dissection for clinically N0 laryngeal carcinoma?
    Lim YC; Choi EC; Lee JS; Koo BS; Song MH; Shin HA
    Oral Oncol; 2006 Jan; 42(1):102-7. PubMed ID: 16143563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic effectiveness of selective neck dissection in the N0 irradiated neck.
    Solares CA; Fritz MA; Esclamado RM
    Head Neck; 2005 May; 27(5):415-20. PubMed ID: 15712298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell carcinoma of the temporal bone: a radiographic-pathologic correlation.
    Gillespie MB; Francis HW; Chee N; Eisele DW
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):803-7. PubMed ID: 11448354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma.
    Gourin CG; Conger BT; Porubsky ES; Sheils WC; Bilodeau PA; Coleman TA
    Laryngoscope; 2008 Jul; 118(7):1191-4. PubMed ID: 18391764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elective neck dissection in early-stage oral squamous cell carcinoma--does it influence recurrence and survival?
    Capote A; Escorial V; Muñoz-Guerra MF; Rodríguez-Campo FJ; Gamallo C; Naval L
    Head Neck; 2007 Jan; 29(1):3-11. PubMed ID: 17103411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
    O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
    Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neck dissection in the treatment of carcinoma of the anterior two-thirds of the tongue.
    Mendelson BC; Woods JE; Beahrs OH
    Surg Gynecol Obstet; 1976 Jul; 143(1):75-80. PubMed ID: 936054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elective neck dissection for carcinomas of the oral cavity: occult metastases, neck recurrences, and adjuvant treatment of pathologically positive necks.
    Zbären P; Nuyens M; Caversaccio M; Stauffer E
    Am J Surg; 2006 Jun; 191(6):756-60. PubMed ID: 16720144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective neck dissection (IIA, III): a rational replacement for complete functional neck dissection in patients with N0 supraglottic and glottic squamous carcinoma.
    Ferlito A; Silver CE; Rinaldo A
    Laryngoscope; 2008 Apr; 118(4):676-9. PubMed ID: 18182969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.